Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Akouos Inc (NQ: AKUS )

3.190 +0.150 (+4.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 75,002
Open 3.010
Bid (Size) 3.190 (1)
Ask (Size) 3.210 (1)
Prev. Close 3.040
Today's Range 3.010 - 3.400
52wk Range 2.315 - 13.69
Shares Outstanding 34,626,156
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Tesla, Twitter And 76 Biggest Movers From Friday
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board... 
Via Benzinga
Stocks Remain Shaky Midweek, Dow Sporting Muted Gains
As the first half of 2022 draws to an end, stocks continue to struggle for direction. 
Via Talk Markets

Performance

YTD
-64.87%
-64.87%
1 Month
-17.99%
-17.99%
3 Month
+15.58%
+15.58%
6 Month
-44.04%
-44.04%
1 Year
-73.83%
-73.83%

More News

Read More
Akouos: Q1 Earnings Insights
Via Benzinga
Recap: Akouos Q4 Earnings
Via Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
Via Benzinga
U.S. Stocks Turn Negative; 2U Shares Spike Higher
Via Benzinga
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Via Benzinga
Exposures COVID-19
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
Via Benzinga
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Zendesk, Quotient, + 40 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
11 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
91 Biggest Movers From Friday
Via Benzinga
79 Biggest Movers From Yesterday
Via Benzinga
Boston Named World's Top Biotech Hub as the City's Leading Biotech Companies Continue to Make Major Breakthroughs
Via Benzinga
65 Biggest Movers From Yesterday
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
65 Biggest Movers From Yesterday
Via Benzinga
5 Value Stocks In The Healthcare Sector
Via Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
Via Benzinga
Akouos' Hearing Loss Gene Therapy Poised To Receive Orphan Drug Tag In Europe
Via Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.